Pain and nociception: Mechanisms of cancer-induced bone pain

Journal of Clinical Oncology

Volumn 32, Issue 16, 2014, Pages 1647-1654

  Falk, Sarah ^a   Dickenson, Anthony H ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; BONE ATROPHY; BONE DESTRUCTION; BONE METASTASIS; BONE PAIN; BREAKTHROUGH PAIN; CANCER CELL; CANCER DIAGNOSIS; CANCER PAIN; CANCER PATIENT; CANCER SURVIVAL; CHRONIC PAIN; DENERVATION; HUMAN; INFLAMMATORY PAIN; NERVE COMPRESSION; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; OSTEOLYSIS; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SENSITIZATION; SENSORY NERVE; SPINAL CORD DORSAL HORN; SPINAL CORD NERVE CELL; SURVIVAL TIME; TUMOR GROWTH; TUMOR VOLUME;

ANIMALS; BONE AND BONES; HUMANS; NEOPLASMS; NOCICEPTION; PAIN;

EID: 84905818291     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2013.51.7219     Document Type: Review

References (84)

1. Loeser JD, Melzack R. Pain: An overview. Lancet 353:1607-1609, 1999 (Pubitemid 29219220)
2. Tracey I, Mantyh PW: The cerebral signature for pain perception and its modulation. Neuron 55:377-391, 2007 (Pubitemid 47161056)
3. Dickenson AH, Matthews EA, Suzuki R: Neurobiology of neuropathic pain: Mode of action of anticonvulsants. Eur J Pain 6:51-60, 2002 (suppl A) (Pubitemid 40023570)
4. Harvey VL, Dickenson AH: Mechanisms of pain in nonmalignant disease. Curr Opin Support Palliat Care 2:133-139, 2008
5. Schaible HG: Mechanisms of chronic pain in osteoarthritis. Curr Rheumatol Rep 14:549-556, 2012
6. Basbaum AI, Bautista DM, Scherrer G, et al: Cellular and molecular mechanisms of pain. Cell 139:267-284, 2009
7. Sabino MA, Mantyh PW: Pathophysiology of bone cancer pain. J Support Oncol 3:15-24, 2005 (Pubitemid 41029576)
8. Mantyh PW: Central pain, in Koltzenburg M, McMahon SB (eds): Wall and Melzack's Textbook of Pain (ed 5). Philadelphia, PA, Elsevier, 2006, pp 1087-1098
9. Gordon-Williams R, Dickenson T: Pathophysiology of pain in cancer and other terminal diseases, in Hanks G, Cherny NI, Christakis NA, et al (eds): Oxford Textbook of Palliative Medicine (ed 4). New York, NY, Oxford University Press, 2011, pp 587-599
10. Meuser T, Pietruck C, Radbruch L, et al: Symptoms during cancer pain treatment following WHO-guidelines: A longitudinal follow-up study of symptom prevalence, severity and etiology. Pain 93:247-257, 2001 (Pubitemid 32763182)
11. Portenoy RK, Lesage P: Management of cancer pain. Lancet 353:1695-1700, 1999 (Pubitemid 29224537)
12. Foley KM: Treatment of cancer-related pain. J Natl Cancer Inst Monogr 32:103-104, 2004
13. Portenoy RK, Hagen NA: Breakthrough pain: Definition, prevalence and characteristics. Pain 41:273-281, 1990 (Pubitemid 20187930)
14. Mercadante S, Arcuri E: Breakthrough pain in cancer patients: Pathophysiology and treatment. Cancer Treat Rev 24:425-432, 1998 (Pubitemid 29121682)
15. Portenoy RK, Payne D, Jacobsen P: Breakthrough pain: Characteristics and impact in patients with cancer pain. Pain 81:129-134, 1999 (Pubitemid 29199908)
16. Mercadante S: Malignant bone pain: Pathophysiology and treatment. Pain 69:1-18, 1997
17. Mercadante S, Maddaloni S, Roccella S, et al: Predictive factors in advanced cancer pain treated only by analgesics. Pain 50:151-155, 1992
18. Bruera E, Schoeller T, Wenk R, et al: A prospective multicenter assessment of the Edmonton staging system for cancer pain. J Pain Symptom Manage 10:348-355, 1995
19. Mantyh WG, Jimenez-Andrade JM, Stake JI, et al: Blockade of nerve sprouting and neuroma formation markedly attenuates the development of late stage cancer pain. Neuroscience 171:588-598, 2010
20. Kostenuik PJ, Orr FW, Suyama K, et al: Increased growth rate and tumor burden of spontaneously metastatic Walker 256 cancer cells in the skeleton of bisphosphonate-treated rats. Cancer Res 53:5452-5457, 1993 (Pubitemid 23342166)
21. Sasaki A, Yoneda T, Terakado N, et al: Experimental bone metastasis model of the oral and maxillofacial region. Anticancer Res 18:1579-1584, 1998 (Pubitemid 28342563)
22. Schwei MJ, Honore P, Rogers SD, et al: Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain. J Neurosci 19:10886-10897, 1999 (Pubitemid 30235733)
23. Pacharinsak C, Beitz A: Animal models of cancer pain. Comp Med 58:220-233, 2008 (Pubitemid 351954728)
24. Medhurst SJ, Walker K, Bowes M, et al: A rat model of bone cancer pain. Pain 96:129-140, 2002 (Pubitemid 34270635)
25. Sabino MA, Luger NM, Mach DB, et al: Different tumors in bone each give rise to a distinct pattern of skeletal destruction, bone cancer-related pain behaviors and neurochemical changes in the central nervous system. Int J Cancer 104:550-558, 2003 (Pubitemid 36337254)
26. Wacnik PW, Eikmeier LJ, Ruggles TR, et al: Functional interactions between tumor and peripheral nerve: Morphology, algogen identification, and behavioral characterization of a new murine model of cancer pain. J Neurosci 21:9355-9366, 2001 (Pubitemid 33096879)
27. Wacnik PW, Kehl LJ, Trempe TM, et al: Tumor implantation in mouse humerus evokes movement-related hyperalgesia exceeding that evoked by intramuscular carrageenan. Pain 101:175-186, 2003 (Pubitemid 36044665)
28. Menéndez L, Lastra A, Fresno MF, et al: Initial thermal heat hypoalgesia and delayed hyperalgesia in a murine model of bone cancer pain. Brain Res 969:102-109, 2003 (Pubitemid 36369617)
29. Falk S, Uldall M, Appel C, et al: Influence of sex differences on the progression of cancer-induced bone pain. Anticancer Res 33:1963-1969, 2013
30. Calvo W, Forteza-Vila J: On the development of bone marrow innervation in new-born rats as studied with silver impregnation and electron microscopy. Am J Anat 126:355-371, 1969
31. Hara-Irie F, Amizuka N, Ozawa H: Immunohistochemical and ultrastructural localization of CGRP-positive nerve fibers at the epiphyseal trabecules facing the growth plate of rat femurs. Bone 18:29-39, 1996 (Pubitemid 26047530)
32. Mach DB, Rogers SD, Sabino MC, et al: Origins of skeletal pain: Sensory and sympathetic innervation of the mouse femur. Neuroscience 113:155-166, 2002 (Pubitemid 34786021)
33. Thurston TJ: Distribution of nerves in long bones as shown by silver impregnation. J Anat 134:719-728, 1982
34. Mantyh PW, Clohisy DR, Koltzenburg M, et al: Molecular mechanisms of cancer pain. Nat Rev Cancer 2:201-209, 2002 (Pubitemid 37328789)
35. Apfel SC: Neurotrophic factors and pain. Clin J Pain 16:S7-S11, 2000
36. Dray A: Inflammatory mediators of pain. Br J Anaesth 75:125-131, 1995
37. Funk CD: Prostaglandins and leukotrienes: Advances in eicosanoid biology. Science 294:1871-1875, 2001
38. Ueno A, Oh-ishi S: Critical roles for bradykinin and prostanoids in acute inflammatory reactions: A search using experimental animal models. Curr Drug Targets Inflamm Allergy 1:363-376, 2002
39. Serre CM, Farlay D, Delmas PD, et al: Evidence for a dense and intimate innervation of the bone tissue, including glutamate-containing fibers. Bone 25:623-629, 1999 (Pubitemid 29525427)
40. Jimenez-Andrade JM, Mantyh WG, Bloom AP, et al: A phenotypically restricted set of primary afferent nerve fibers innervate the bone versus skin: Therapeutic opportunity for treating skeletal pain. Bone 46:306-313, 2010
41. Ivanusic JJ: Size, neurochemistry, and segmental distribution of sensory neurons innervating the rat tibia. J Comp Neurol 517:276-283, 2009
42. Peters CM, Ghilardi JR, Keyser CP, et al: Tumor-induced injury of primary afferent sensory nerve fibers in bone cancer pain. Exp Neurol 193:85-100, 2005 (Pubitemid 40463270)
43. Jimenez-Andrade JM, Ghilardi JR, Castañeda-Corral G, et al: Preventive or late administration of anti-NGF therapy attenuates tumor-induced nerve sprouting, neuroma formation, and cancer pain. Pain 152:2564-2574, 2011
44. Jänig W, Baron R: Complex regional pain syndrome: Mystery explained? Lancet Neurol 2:687-697, 2003 (Pubitemid 37311322)
45. Spierings EL, Fidelholtz J, Wolfram G, et al: A phase III placebo- and oxycodone-controlled study of tanezumab in adults with osteoarthritis pain of the hip or knee. Pain 154:1603-1612, 2013
46. Hill R: Blocking the effects of NGF as a route to safe and effective pain relief: Fact or fancy? Pain 152:2200-2201, 2011
47. Blair HC: How the osteoclast degrades bone. Bioessays 20:837-846, 1998
48. Honoré P, Schwei J, Rogers SD, et al: Cellular and neurochemical remodeling of the spinal cord in bone cancer pain. Prog Brain Res 129:389-397, 2000 (Pubitemid 35461210)
49. Halvorson KG, Sevcik MA, Ghilardi JR, et al: Similarities and differences in tumor growth, skeletal remodeling and pain in an osteolytic and osteoblastic model of bone cancer. Clin J Pain 22:587-600, 2006 (Pubitemid 44310159)
50. Julius D, Basbaum AI: Molecular mechanisms of nociception. Nature 413:203-210, 2001 (Pubitemid 32867885)
51. Colvin L, Fallon M: Challenges in cancer pain management: Bone pain. Eur J Cancer 44:1083-1090, 2008
52. Urch C: The pathophysiology of cancer-induced bone pain: Current understanding. Palliat Med 18:267-274, 2004
53. Clohisy DR, Perkins SL, Ramnaraine ML: Review of cellular mechanisms of tumor osteolysis. Clin Orthop Relat Res 373:104-114, 2000 (Pubitemid 30225664)
54. Schwarz EM, Ritchlin CT: Clinical development of anti-RANKL therapy. Arthritis Res Ther 9:S7, 2007 (suppl 1)
55. Lipton A, Goessl C: Clinical development of anti-RANKL therapies for treatment and prevention of bone metastasis. Bone 48:96-99, 2011
56. Drake MT, Clarke BL, Khosla S: Bisphosphonates: Mechanism of action and role in clinical practice. Mayo Clin Proc 83:1032-1045, 2008
57. Safieh-Garabedian B, Poole S, Allchorne A, et al: Contribution of interleukin-1 beta to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia. Br J Pharmacol 115:1265-1275, 1995
58. Sorkin LS, Xiao WH, Wagner R, et al: Tumour necrosis factor-alpha induces ectopic activity in nociceptive primary afferent fibres. Neuroscience 81:255-262, 1997 (Pubitemid 27373645)
59. Patel S, Dickenson AH: Mechanisms of cancer pain: Experimental data, in Mogel J (ed): Pain 2010: An Updated Review-Refresher Course Syllabus. Washington, DC, IASP Press, 2010, pp 27-35
60. Vasko MR: Prostaglandin-induced neuropeptide release from spinal cord. Prog Brain Res 104:367-380, 1995
61. Chen EP, Smyth EM: COX-2 and PGE2-dependent immunomodulation in breast cancer. Prostaglandins Other Lipid Mediat 96:14-20, 2011
62. Fox A, Medhurst S, Courade JP, et al: Antihyperalgesic activity of the cox-2 inhibitor lumiracoxib in a model of bone cancer pain in the rat. Pain 107:33-40, 2004 (Pubitemid 38058696)
63. Sabino MA, Ghilardi JR, Jongen JL, et al: Simultaneous reduction in cancer pain, bone destruction, and tumor growth by selective inhibition of cyclooxygenase-2. Cancer Res 62:7343-7349, 2002 (Pubitemid 36025258)
64. Sheng H, Shao J, Kirkland SC, et al: Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J Clin Invest 99:2254-2259, 1997 (Pubitemid 27203783)
65. Falk S, Uldall M, Heegaard AM: The role of purinergic receptors in cancer-induced bone pain. J Osteoporos 2012:758181, 2012
66. Kaan TK, Yip PK, Patel S, et al: Systemic blockade of P2X3 and P2X2/3 receptors attenuates bone cancer pain behaviour in rats. Brain 133:2549-2564, 2010
67. González-Rodriguez S, Pevida M, Roques BP, et al: Involvement of enkephalins in the inhibition of osteosarcoma-induced thermal hyperalgesia evoked by the blockade of peripheral P2X3 receptors. Neurosci Lett 465:285-289, 2009
68. Hansen RR, Nasser A, Falk S, et al: Chronic administration of the selective P2X3, P2X2/3 receptor antagonist, A-317491, transiently attenuates cancer-induced bone pain in mice. Eur J Pharmacol 688:27-34, 2012
69. Wu JX, Xu MY, Miao XR, et al: Functional up-regulation of P2X3 receptors in dorsal root ganglion in a rat model of bone cancer pain. Eur J Pain 16:1378-1388, 2012
70. Abbadie C, Besson JM: C-fos expression in rat lumbar spinal cord during the development of adjuvant-induced arthritis. Neuroscience 48:985-993, 1992
71. Wagner R, DeLeo JA, Coombs DW, et al: Spinal dynorphin immunoreactivity increases bilaterally in a neuropathic pain model. Brain Res 629:323-326, 1993 (Pubitemid 23337810)
72. Urch CE, Donovan-Rodriguez T, Dickenson AH: Alterations in dorsal horn neurones in a rat model of cancer-induced bone pain. Pain 106:347-356, 2003 (Pubitemid 37505882)
73. Donovan-Rodriguez T, Dickenson AH, Urch CE: Superficial dorsal horn neuronal responses and the emergence of behavioural hyperalgesia in a rat model of cancer-induced bone pain. Neurosci Lett 360:29-32, 2004 (Pubitemid 38471980)
74. Donovan-Rodriguez T, Dickenson AH, Urch CE: Gabapentin normalizes spinal neuronal responses that correlate with behavior in a rat model of cancer-induced bone pain. Anesthesiology 102:132-140, 2005 (Pubitemid 40082850)
75. Urch CE, Donovan-Rodriguez T, Gordon-Williams R, et al: Efficacy of chronic morphine in a rat model of cancer-induced bone pain: Behavior and in dorsal horn pathophysiology. J Pain 6:837-845, 2005 (Pubitemid 41739601)
76. D'Mello R, Dickenson AH: Spinal cord mechanisms of pain. Br J Anaesth 101:8-16, 2008 (Pubitemid 351881902)
77. Gu X, Zhang J, Ma Z, et al: The role of N-methyl-D-aspartate receptor subunit NR2B in spinal cord in cancer pain. Eur J Pain 14:496-502, 2010
78. Menéndez L, Lastra A, Hidalgo A, et al: Peripheral opioids act as analgesics in bone cancer pain in mice. Neuroreport 14:867-869, 2003 (Pubitemid 36667928)
79. Luger NM, Sabino MA, Schwei MJ, et al: Efficacy of systemic morphine suggests a fundamental difference in the mechanisms that generate bone cancer vs inflammatory pain. Pain 99:397-406, 2002 (Pubitemid 35284270)
80. Vermeirsch H, Nuydens RM, Salmon PL, et al: Bone cancer pain model in mice: Evaluation of pain behavior, bone destruction and morphine sensitivity. Pharmacol Biochem Behav 79:243-251, 2004 (Pubitemid 40029226)
81. El Mouedden M, Meert TF: The impact of the opioids fentanyl and morphine on nociception and bone destruction in a murine model of bone cancer pain. Pharmacol Biochem Behav 87:30-40, 2007 (Pubitemid 46855816)
82. El Mouedden M, Meert TF: Evaluation of pain-related behavior, bone destruction and effectiveness of fentanyl, sufentanil, and morphine in a murine model of cancer pain. Pharmacol Biochem Behav 82:109-119, 2005
83. Gonçalves L, Dickenson AH: Asymmetric time-dependent activation of right central amygdala neurones in rats with peripheral neuropathy and pregabalin modulation. Eur J Neurosci 36:3204-3213, 2012
84. Bannister K, Bee LA, Dickenson AH: Preclinical and early clinical investigations related to monoaminergic pain modulation. Neurotherapeutics 6:703-712, 2009